Review: Abnormal Substrate Metabolism and Nutritional Strategies in Cancer Management
- 1 November 1991
- journal article
- review article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 15 (6) , 680-683
- https://doi.org/10.1177/0148607191015006680
Abstract
Impairment of the nutritional state plays a major role in the morbidity and mortality of cancer patients. However, the opportunity of providing artificial nutritional support to these patients is still debated, because of the concern that energy substrates administered to replete the host may concomitantly stimulate tumor growth. A correct nutritional approach to cancer patients should thus be based on a thorough knowledge of both host and tumor metabolic needs and host-tumor metabolic interactions. Specific modifications of plasma levels of glucogenic, aromatic, sulfur-containing and branched-chain amino acids have been demonstrated in cancer patients, indicating a specific influence of the tumor on amino acid metabolism. Little is known about protein metabolism in neoplastic tissue. Interference with tumor growth has been attempted by deprivation of single amino acids with controversial results. Increased gluconeogenesis and insulin resistance are responsible for the two main abnormalities in carbohydrate metabolism in cancer patients, namely increased glucose turnover and impaired glucose tissue disposal. Lipid metabolism is also affected by the neoplasm: soluble factors such as "lipid-mobilizing factor" lead to increased fat mobilization from adipose tissue; plasma elimination of exogenous triglycerides has also been found to be reduced probably because of a tumor-related decrease in lipoprotein lipase activity. The differences in glucose and fat utilization between tumor and host should be considered in the nutritional approach to cancer patients. Data in this respect are controversial and have been obtained only in experimental animals. In a recent study comparing the effects of a glucose-based vs a lipid-based parenteral nutritional regimen, on tumor growth in man, we showed that lipid-based parenteral nutrition reduces, although not significantly, tumor growth rate. Nutritional manipulation of cancer is rapidly moving from theory to reality, offering nutritionists and oncologists a valid tool in cancer patient's careKeywords
This publication has 37 references indexed in Scilit:
- Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patientsClinical Nutrition, 1991
- Plasma and CSF tryptophan in cancer anorexiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Plasma amino-acids in human cancer: the individual role of tumour, malnutrition and glucose toleranceClinical Nutrition, 1988
- Amino acid profiles in tumor-bearing and pair-fed nontumor-bearing malnourished ratsCancer, 1988
- Reduction of tumor growth following treatment with a glutamine antimetaboliteLife Sciences, 1988
- The effect of energy substrate manipulation on tumor growth and metastasis and intermediary metabolism in the parenterally fed mouseJournal of Pediatric Surgery, 1985
- Response of tumor-bearing rats to high-fat total parenteral nutritionCancer, 1985
- Alteration of tumor cell kinetics by pulse total parenteral nutrition. Potential therapeutic implicationsCancer, 1984
- Plasma amino acids imbalance in patients with liver diseaseDigestive Diseases and Sciences, 1978
- Effects of reducing the phenylalanine-Tyrosine intake of patients with advanced malignant melanomaCancer, 1966